Skip to main content
Caplight Logo









Kuano

Kuano

Private
CambridgeHealthcare & Life Scienceshttps://www.kuano.ai/

Last Round

Seed

Sep 12, 2023

Total Funding Raised

$3.63M

Company Overview

Kuano is a drug discovery company that has developed a platform combining quantum mechanics and AI to design the next generation of medicines targeting enzymes.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Quantum Computing, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Subscription SaaS

AI Layer

Application

Keywords

AI drug discoveryenzyme inhibitorsquantum drug discoveryundruggable targetsdrug discovery platformquantum simulationde novo drug designphysics-informed AIenzyme transition statecomputational drug discoveryhit identificationin silico drug discoverylead optimizationgenerative chemistrypreclinical drug candidates

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kuano Comparables

Compare Kuano with similar companies based on industry and business-model similarity.

Kuano comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PolarisQB
88%
Qubit Pharmaceuticals
86%
Axiom Therapeutics
85%

Kuano Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 12, 2023
SeedJul 8, 2021
Pre SeedFeb 25, 2021
AcceleratorJan 1, 2021

Key People

Founding team and executive leadership

David Wright

CTO Founder

Founding Team

Vid Stojevic

Co-Founder and CEO

Founding Team

Kuano Investors

Notable investors and investment history

Kuano investors
InvestorRounds
Ascension VenturesSeed
ACF InvestorsSeed
Cambridge AngelsPre Seed, Seed
o2h venturesSeed, Pre Seed
Meltwind AdvisorySeed, Pre Seed
Creative Destruction LabAccelerator
Mercia Asset ManagementSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 2, 2025

    Monthly visitors grew 366% MoM, from 537 to 2.5K.

  • Jan 2, 2024

    Grew 20% QoQ, from 15 to 18 employees.

Kuano Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kuano Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kuano's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range13
Year Founded2020
Last FundingSep 12, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?